Altimmune
ALT
57 hedge funds and large institutions have $143M invested in Altimmune in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 6 closing their positions.
2,700% more capital invested
Capital invested by funds: $5.1M → $143M (+$138M)
550% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 2
467% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 6
254% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $4.4M
97% more funds holding
Funds holding: 29 → 57 (+28)
55.93% more ownership
Funds ownership: 10.34% → 66.27% (+56%)
Top Buyers
| 1 |
VA
VR Adviser
New York
|
+$24.7M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$11.6M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$4.29M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.13M |
| 5 |
BlackRock
New York
|
+$2.99M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TFA
51
Toth Financial Advisory
Leesburg,
Virginia
| $3K | – | – | – |
|
52
Wells Fargo
San Francisco,
California
| $3K | +$1.1K | +201 | +231% |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $3K | +$1.61K | +293 | New |
|
|
BWA
54
Burt Wealth Advisors
North Bethesda,
Maryland
| $1K | – | – | – |
|
55
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
56
Victory Capital Management
San Antonio,
Texas
| – | -$16K | -4,676 | Closed |
|
|
PAM
57
Panagora Asset Management
Boston,
Massachusetts
| – | -$3K | -1,010 | Closed |
|
|
APA
58
American Portfolios Advisors
Holbrook,
New York
| – | -$3.21K | -1,000 | Closed |
|
|
GSWM
59
Golden State Wealth Management
Santa Ana,
California
| – | -$3K | -975 | Closed |
|
60
Simplex Trading
Chicago,
Illinois
| – | -$516 | -94 | Closed |
|
|
PAG
61
Private Advisor Group
Morristown,
New Jersey
| – | +$22 | +4 | New |
|
ALT Hedge Fund Activity: Q2 2020 in Review
57 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2020, worth a combined $143M — up 2,700% from $5.1M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ALT positions and 6 closed out — a net gain of 28 holders — while 13 added to existing stakes and 2 trimmed.
The largest buyer was VR Adviser, opening a new position worth an estimated $24.7M. The largest seller was Victory Capital Management, exiting entirely with an estimated $16K sold.
- 57 institutional investors held Altimmune (ALT) as of Q2 2020, up from 29 in Q1 2020.
- Funds reported $143M of Altimmune stock for Q2 2020, up 2,700% quarter-over-quarter.
- 34 funds opened new Altimmune positions in Q2 2020 and 6 closed out, a net change of +28 holders.
- The largest Altimmune buyer in Q2 2020 was VR Adviser, an estimated $24.7M added.
- The largest Altimmune seller in Q2 2020 was Victory Capital Management, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2020.